NEW YORK (GenomeWeb News) – Italian pharmaceutical and diagnostics firm the Menarini Group has acquired Bologna-based Silicon Biosystems for an undisclosed sum, the firms announced today.

Silicon Biosystems has commercialized a microelectronic array-based platform, called DEPArray, that can isolate and manipulate cells, including rare cells such as stem cells and circulating tumor cells, in a suspension matrix.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.